Skip to search formSkip to main contentSkip to account menu

Vastarel MR

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Trimetazidina (Vastarel®): benefícios não superam os riscos para o tratamento de zumbidos, vertigens e distúrbios do campo visual
2014
2014
RR 434 - 2014 NATS Clopidogrel, Procoralan®, Vastarel®, Sustrate® e Apresolina®
2011
2011
Les médicaments sont-ils devenus plus dangereux ?
Depuis l'eclatement de l'affaire Mediator® a l'automne dernier, la liste des medicaments retires du marche en raison de leur… 
Review
2009
Review
2009
Beneficial long-term effects of Vastarel MR in patients with stable coronary artery disease developing left ventricular dysfunction
During the past two decades, the management of chronic coronary artery diseases has improved considerably, as a result of both… 
2002
2002
Evaluation des effets de Vastarel® 35mg chez les patients presentant une atteinte vestibulaire périphérique : Etude à double insu contrôlée versus placebo, utilisant comme critère de jugement l…
Objectifs : l'EquiTest permet de tester l'equilibre dans les conditions physiologiques et de completer objectivement les echelles… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)